Understanding Patient and Caregiver Preferences for Risperidone Dosage Forms Including Patch Medication

What this Trial Is About

This research aims to understand the needs and preferences of patients and their caregivers regarding different forms of antipsychotic medications, specifically focusing on risperidone. It seeks to clarify the clinical value of a patch-form antipsychotic for conditions such as schizophrenia, bipolar disorder, autism spectrum disorder, conduct disorder, and mental retardation. The study is observational and sponsored by the Shanghai Mental Health Center. Participants include patients diagnosed with the mentioned psychiatric disorders or their primary caregivers. The study observes their preferences for risperidone dosage forms, particularly the patch form, without administering any investigational treatment. The study is planned to last for about six months, during which researchers will track patient and caregiver preferences. During the study, participants will be asked about their preferences for risperidone patch-form medicine and related factors influencing these preferences. Researchers will collect data through questionnaires or interviews over the six-month period. The primary measure is the proportion of patients and caregivers who prefer the patch form, with secondary measures focusing on factors influencing this preference. Participation involves ongoing observation without intervention, ensuring safety and respect for individual choices.

A Study on the Preference of Risperidone Dosage Forms